De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 191-200

  Honda, Kazuho ^a   Horita, Shigeru ^a   Toki, Daisuke ^a   Taneda, Sekiko ^a   Nitta, Kosaku ^a   Hattori, Motoshi ^a   Tanabe, Kazunari ^a   Teraoka, Satoshi ^a   Oda, Hideaki ^a   Yamaguchi, Yutaka ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody mediated rejection; de novo glomerulonephritis; Donor specific antibody; Human leukocyte antigen; Membranous nephropathy

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS CAPILLARY; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA;

ADULT; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79953306238     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01213.x     Document Type: Article

References (23)

1. Habib R, Antignac C, Hinglais N, Gagnadoux MF, Broyer M. Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis 1987: 10: 198.
2. Schwarz A, Krause PH, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991: 17: 524.
3. Schwarz A, Krause PH, Offermann G, Keller F. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation 1994: 58: 650.
4. Monga G, Mazzucco G, Basolo B et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1993: 6: 249.
5. Morales JM, Pascual-Capdevila J, Campistol JM et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997: 63: 1634.
6. Ozdemir BH, Ozdemir FN, Sezer S, Colak T, Haberal M. De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc 2006: 38: 492.
7. Truong L, Gelfand J, D'Agati V et al. De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature. Am J Kidney Dis 1989: 14: 131.
8. Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D. Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 1988: 11: 188.
9. Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clin Nephrol 1992: 37: 115.
10. Imai H, Oyama Y, Miura AB, Endoh M, Sakai H. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 2000: 36: 474.
11. Lin J, Markowitz GS, Nicolaides M et al. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 2001: 21: 351.
12. Colombo AA, Rusconi C, Esposito C et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006: 81: 1087.
13. El Kossi M, Harmer A, Goodwin J et al. De novo membranous nephropathy associated with donor-specific alloantibody. Clin Transplant 2008: 22: 124.
14. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993: 44: 411.
15. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003: 3: 708.
16. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007: 7: 518.
17. Ehrenreich T, Churg J. Pathology of membranous nephropathy. Pathol Annu 1968: 3: 145.
18. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993: 43: 1333.
19. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999: 10: 2208.
20. Nickeleit V, Andreoni K. The classification and treatment of antibody-mediated renal allograft injury: where do we stand? Kidney Int 2007: 71: 7.
21. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007: 18: 1046.
22. Aita K, Yamaguchi Y, Horita S et al. Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts. Am J Transplant 2007: 7: 923.
23. Colvin RB, Nickeleit V. Acute antibody-mediated rejection. Etiology and pathogenesis. In: Jennette JC, Olsen JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 6th edn. Volume II. Tokyo: Lippincott Williams & Wilkins, 2007: 1387.